Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0S3IG
|
|||
| Former ID |
DIB016501
|
|||
| Drug Name |
SCH-10363
|
|||
| Synonyms |
SCH-414352; SCH-446211; SCH-540446; SCH-544040; SCH-6; SCH-644342; SCH-644343; SCH-9301; HCV NS3 protease inhibitors, Merck & Co; HCV NS3 protease inhibitors, Schering-Plough; HCV helicase inhibitors, Merck & Co; HCV helicase inhibitors, Schering-Plough; Boceprevir analogs (HCV infection), Merck & Co; Boceprevir analogs (HCV infection), Schering-Plough; HCV NS3 protease inhibitors (hepatitis C virus), Schering-Plough; NS3 serine protease inhbitor (hepatitis C virus therapy), Schering-Plough
Click to Show/Hide
|
|||
| Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Investigative | [1] | |
| Company |
Schering-Plough Corp
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.